Terrie Curran
Board of Director
Biopharmaceuticals
Roivant Sciences
Switzerland
Biography
Terrie Curran is the President of Worldwide Markets for the Inflammation & Immunology portfolio at Celgene Corporation and previously served as Senior Vice President and General Manager of Women’s Health and Endocrinology at Merck and Co., Inc. Ms. Curran earned her Bachelor of Science and Graduate Diploma of Marketing degrees from the University of Technology in Sydney, Australia.
Research Interest
Business Administration
